Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  18F-fluoromisonidazole
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
A Phase 2 Study of Cediranib in Combination with Olaparib in Advanced Solid Tumors
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9881, NCI-2015-01097, 1604017576, NCT02498613
18F-EF5 PET and Biospecimen Collection in Measuring Hypoxia in Patients with Solid Tumors
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 18 and over
Trial IDs: VAR0032, NCI-2017-01326, NCT01123005
18F-FMISO Positron Emission Tomography in Detecting Hypoxia in Patients with Colorectal Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 07-151, NCI-2016-01705, NCT00574353
18F-Fluoromisonidazole-, Fludeoxyglucose F18-, and Water O-15-Labeled PET in Measuring Tumor Hypoxia in Patients with Newly Diagnosed Brain Tumors or Brain Metastases
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: HCI44704, NCI-2011-03663, NCT01246869
18F-FMISO Breath-Hold PET/CT in Measuring Tumor Hypoxia in Patients with Non-small Cell Lung Cancer Receiving Treatment
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 13-186, NCI-2015-00271, NCT02016872
FMISO PET and Vascular MRI in Measuring Blood and Oxygen Flow in Patients with Recurrent Glioblastoma Receiving Bevacizumab with or without Lomustine
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 13-482, NCI-2014-00945, NCT02076152
[18F]FMISO PET/CT after Transcatheter Arterial Embolization in Imaging Tumors in Patients with Liver Cancer
Status: Not yet active
Phase: No phase specified
Type: Diagnostic
Age: 19 and over
Trial IDs: HEP0055, NCI-2016-00041, 29768, NCT02695628
Start Over